Modifications of extrinsic pathway inhibitor (EPI) and factor Xa that affect their ability to interact and to inhibit factor VIIa/tissue factor: evidence for a two-step model of inhibition.
Inhibition of factor VIIa/tissue factor (TF) by extrinsic pathway inhibitor (EPI) requires the participation of factor Xa. Through this inhibition, factor Xa generated initially may feed back to suppress continuing generation of factor Xa via the extrinsic pathway during hemostasis. We have utilized chemical modifications of EPI and factor Xa to study the reactions responsible for inhibition. The data are consistent with a two-step model. First, EPI binds to factor Xa in a Ca2+ independent reaction in which the gla-domain of factor Xa does not participate. A functional active site on factor Xa and arginine residues on EPI are essential for this step. Then the factor Xa/EPI complex binds to factor VIIa/TF with resultant inhibition of its enzymatic activity. The gla-domain of factor Xa is essential for this step. Intact positively charged lysines on factor Xa may also be important.
Warn-Cramer
B J
BJ
Department of Medicine, University of California, San Diego, La Jolla 92103.
Rao
L V
LV
Maki
S L
SL
Rapaport
S I
SI
D001120:Arginine / Q000378:metabolism; D001667:Binding, Competitive; D001777:Blood Coagulation; D015951:Factor Xa; D006801:Humans; D008074:Lipoproteins; D009363:Neoplasm Proteins / Q000378:metabolism*; D012697:Serine Endopeptidases / Q000378:metabolism*; D015842:Serine Proteinase Inhibitors; D013925:Thromboplastin / Q000037:antagonists & inhibitors*
D008074:Lipoproteins; D009363:Neoplasm Proteins; D015842:Serine Proteinase Inhibitors; C051928:lipoprotein-associated coagulation inhibitor; D013925:Thromboplastin; D001120:Arginine; D012697:Serine Endopeptidases; D015951:Factor Xa